UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy

Breast cancer research : BCR, 2011-04, Vol.13 (2), p.R35-R35, Article R35

2011

Volltextzugriff (PDF)

PXR Pharmacogenetics: Association of Haplotypes with Hepatic CYP3A4 and ABCB1 Messenger RNA Expression and Doxorubicin Clearance in Asian Breast Cancer Patients

Clinical cancer research, 2008-11, Vol.14 (21), p.7116-7126

2008

Volltextzugriff (PDF)

CBR1 and CBR3 pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients

Cancer science, 2008-10, Vol.99 (10), p.2045-2054

2008

Volltextzugriff (PDF)

Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients

Breast cancer research and treatment, 2006-09, Vol.99 (1), p.63-69

2006

Volltextzugriff (PDF)

Measurement Properties of the Eight-Item Abbreviated Functional Assessment of Cancer Therapy—Breast Symptom Index and Comparison With Its 37-Item Parent Measure

Journal of pain and symptom management, 2013-04, Vol.45 (4), p.782-791

2013

Volltextzugriff (PDF)

Role of gonadotropin-releasing hormone analog in the management of male metastatic breast cancer is uncertain

Journal of clinical oncology, 2007-08, Vol.25 (24), p.3787-3787

2007

Volltextzugriff (PDF)

Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers

The American journal of surgical pathology, 2010-07, Vol.34 (7), p.956-964

2010

Volltextzugriff (PDF)

Hormone Receptor and c-ERBB2 Status in Distant Metastatic and Locally Recurrent Breast Cancer: Pathologic Correlations and Clinical Significance

American journal of clinical pathology, 2010-03, Vol.133 (3), p.416-429

2010

Volltextzugriff (PDF)

Hormone Receptor and c-ERBB2 Status in Distant Metastatic and Locally Recurrent Breast Cancer

American journal of clinical pathology, 2010-03, Vol.133 (3), p.416-429

2010

Volltextzugriff (PDF)

Evaluation of three polygenic risk score models for the prediction of breast cancer risk in Singapore Chinese

Oncotarget, 2018-02, Vol.9 (16), p.12796-12804

2018

Volltextzugriff (PDF)

Phase I/II Trial of Metronomic Chemotherapy With Daily Dalteparin and Cyclophosphamide, Twice-Weekly Methotrexate, and Daily Prednisone As Therapy for Metastatic Breast Cancer Using Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor Levels As Markers of Response

Journal of clinical oncology, 2010-02, Vol.28 (5), p.723-730

2010

Volltextzugriff (PDF)

Therapeutic targets in triple negative breast cancer - where are we now?

Recent patents on anti-cancer drug discovery, 2011-05, Vol.6 (2), p.196-209

2011

Volltextzugriff (PDF)

Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab

Cancer medicine (Malden, MA), 2013-04, Vol.2 (2), p.234-242

2013

Volltextzugriff (PDF)

Impact of UDP-gluconoryltransferase 2B17 genotype on vorinostat metabolism and clinical outcomes in Asian women with breast cancer

Pharmacogenetics and genomics, 2011-11, Vol.21 (11), p.760-768

2011

Volltextzugriff (PDF)

Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009

The lancet oncology, 2009-11, Vol.10 (11), p.1077-1085

2009

Volltextzugriff (PDF)

Singapore Cancer Network (SCAN) Guidelines for Adjuvant Trastuzumab Use in Early Stage HER2 Positive Breast Cancer

Annals of the Academy of Medicine, Singapore, 2015-10, Vol.44 (10), p.360-367

2015

Volltextzugriff (PDF)

A Phase II Study of Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in the Treatment of Metastatic Colorectal Cancer

Anticancer research, 2011, Vol.31 (1), p.255-261

2011

Volltextzugriff (PDF)

Phase I/II study of gemcitabine with pegylated liposomal doxorubicin as first-line therapy in Asian women with metastatic breast cancer

Breast (Edinburgh), 2008-10, Vol.17 (5), p.517-522

2008

Volltextzugriff (PDF)

Primary medical therapy and breast conservation treatment: the medical oncology perspective

Gland surgery, 2018-12, Vol.7 (6), p.560-575

Wong, Nan Soon

2018

Volltextzugriff (PDF)

Cross‐Ancestry Genome‐Wide Association Study Defines the Extended CYP2D6 Locus as the Principal Genetic Determinant of Endoxifen Plasma Concentrations

Clinical pharmacology and therapeutics, 2023-03, Vol.113 (3), p.712-723

2023

Volltextzugriff (PDF)

Adrenal Insufficiency in Intestinal Obstruction from Carcinomatosis Peritonei—A Factor of Potential Importance in Symptom Palliation

Journal of pain and symptom management, 2005-04, Vol.29 (4), p.411-418

2005

Volltextzugriff (PDF)

Lonafarnib for cancer and progeria

Expert opinion on investigational drugs, 2012-07, Vol.21 (7), p.1043-1055

2012

Volltextzugriff (PDF)

Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial

JAMA oncology, 2017-11, Vol.3 (11), p.1538

2017

Volltextzugriff (PDF)

Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients

Clinical pharmacokinetics, 2016-10, Vol.55 (10), p.1239-1250

2016

Volltextzugriff (PDF)

Comparison of the measurement properties between a short and generic instrument, the 5-level EuroQoL Group's 5-dimension (EQ-5D-5L) questionnaire, and a longer and disease-specific instrument, the Functional Assessment of Cancer Therapy—Breast (FACT-B), in Asian breast cancer patients

Quality of life research, 2013-09, Vol.22 (7), p.1745-1751

2013

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(43)
Berichte
(1)

Sprache

Englisch
(44)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy

PXR Pharmacogenetics: Association of Haplotypes with Hepatic CYP3A4 and ABCB1 Messenger RNA Expression and Doxorubicin Clearance in Asian Breast Cancer Patients

CBR1 and CBR3 pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients

Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients

Measurement Properties of the Eight-Item Abbreviated Functional Assessment of Cancer Therapy—Breast Symptom Index and Comparison With Its 37-Item Parent Measure

Role of gonadotropin-releasing hormone analog in the management of male metastatic breast cancer is uncertain

Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers

Hormone Receptor and c-ERBB2 Status in Distant Metastatic and Locally Recurrent Breast Cancer: Pathologic Correlations and Clinical Significance

Hormone Receptor and c-ERBB2 Status in Distant Metastatic and Locally Recurrent Breast Cancer

Evaluation of three polygenic risk score models for the prediction of breast cancer risk in Singapore Chinese

Therapeutic targets in triple negative breast cancer - where are we now?

Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab

Impact of UDP-gluconoryltransferase 2B17 genotype on vorinostat metabolism and clinical outcomes in Asian women with breast cancer

Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009

Singapore Cancer Network (SCAN) Guidelines for Adjuvant Trastuzumab Use in Early Stage HER2 Positive Breast Cancer

A Phase II Study of Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in the Treatment of Metastatic Colorectal Cancer

Phase I/II study of gemcitabine with pegylated liposomal doxorubicin as first-line therapy in Asian women with metastatic breast cancer

Primary medical therapy and breast conservation treatment: the medical oncology perspective

Cross‐Ancestry Genome‐Wide Association Study Defines the Extended CYP2D6 Locus as the Principal Genetic Determinant of Endoxifen Plasma Concentrations

Adrenal Insufficiency in Intestinal Obstruction from Carcinomatosis Peritonei—A Factor of Potential Importance in Symptom Palliation

Lonafarnib for cancer and progeria

Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial

Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients

Comparison of the measurement properties between a short and generic instrument, the 5-level EuroQoL Group's 5-dimension (EQ-5D-5L) questionnaire, and a longer and disease-specific instrument, the Functional Assessment of Cancer Therapy—Breast (FACT-B), in Asian breast cancer patients

Suchergebnisse filtern